Oppenheimer Lowers Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $16.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price cut by equities researchers at Oppenheimer from $17.00 to $16.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s price objective suggests a potential upside of 86.05% from the company’s current price.

A number of other equities research analysts also recently commented on BIOX. Canaccord Genuity Group reissued a “buy” rating and issued a $17.00 price objective on shares of Bioceres Crop Solutions in a research report on Friday, July 19th. Roth Capital upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Lake Street Capital reduced their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a report on Wednesday. Finally, Roth Mkm assumed coverage on shares of Bioceres Crop Solutions in a report on Tuesday, July 2nd. They set a “buy” rating and a $15.00 price objective on the stock. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $13.63.

Bioceres Crop Solutions Stock Up 0.6 %

NASDAQ BIOX opened at $8.60 on Wednesday. Bioceres Crop Solutions has a 52 week low of $8.16 and a 52 week high of $14.05. The firm has a market cap of $540.05 million, a PE ratio of 860.00 and a beta of 0.49. The business’s fifty day simple moving average is $10.49 and its 200-day simple moving average is $11.45. The company has a quick ratio of 0.83, a current ratio of 1.22 and a debt-to-equity ratio of 0.29.

Bioceres Crop Solutions (NASDAQ:BIOX) last issued its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.23). The company had revenue of $124.30 million during the quarter, compared to analysts’ expectations of $126.75 million. Bioceres Crop Solutions had a net margin of 0.21% and a return on equity of 0.28%. During the same quarter last year, the firm posted ($0.06) earnings per share. As a group, equities analysts anticipate that Bioceres Crop Solutions will post 0.3 earnings per share for the current year.

Institutional Trading of Bioceres Crop Solutions

Several large investors have recently bought and sold shares of BIOX. Fourth Sail Capital LP grew its stake in shares of Bioceres Crop Solutions by 136.1% during the first quarter. Fourth Sail Capital LP now owns 1,627,630 shares of the company’s stock valued at $20,606,000 after acquiring an additional 938,282 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. bought a new position in Bioceres Crop Solutions during the second quarter worth $472,000. Oppenheimer & Co. Inc. acquired a new position in shares of Bioceres Crop Solutions in the 1st quarter valued at about $139,000. Wellington Management Group LLP boosted its stake in Bioceres Crop Solutions by 3.1% in the fourth quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock valued at $3,253,000 after acquiring an additional 7,096 shares during the period. Finally, Ping Capital Management Inc. bought a new position in Bioceres Crop Solutions during the 2nd quarter worth $448,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.